Companies should shift from ‘just in time’ to ‘just in case’ FT. “Ideally, companies should aim for what Nassim Nicholas Taleb has called an ‘antifragile‘ approach, going ‘beyond resilience and robustness’ so that they can adapt to, and even thrive on, disorder.” Hmm. “Thriving on disorder” sounds like “disaster capitalism” a la Shock Doctrine to me (though I’m sure that’s not at all Taleb’s recommendation).
There is a way we could identify more patients who have Covid pneumonia sooner and treat them more effectively — and it would not require waiting for a coronavirus test at a hospital or doctor’s office. It requires detecting silent hypoxia early through a common medical device that can be purchased without a prescription at most pharmacies: a pulse oximeter.
Worth reading in full, even if only as a clinician’s detective story.
Estimating the burden of SARS-CoV-2 in France (PDF) Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur. Bottom line in the abstract: “Population immunity appears insufficient to avoid a second wave if all control measures are released at the end of the lockdown.”
“What it means is we had coronavirus circulating in the community much earlier than we had documented and much earlier than we had thought,” said Dr. Sara Cody, Santa Clara County’s public health officer. “Those deaths probably represent many, many more infections. And so there had to be chains of transmission that go back much earlier.”
Note that the San Francisco region’s early lockdown was driven by Cody.
IDSA COVID-19 Antibody Testing Primer Infectious Diseases Society of America. “A ‘positive’ [antibody] test is exceptionally difficult to interpret because the performance of these tests is not well known.”
Democrats cave: Nothing for states or cities, nothing for election protection or the post office, no oversight, no limits on fossil fuel bailouts, no food stamps. They got some testing – somehow that’s a GOP concession! – but no contact tracing. https://t.co/PWjOoaWozN